| 2025/0114,768 | POROUS PROTEIN STRUCTURES | Jan 27, 23 | Apr 10, 25 | Not available |
| 2025/0115,939 | Neural Repair Protein Composition and Preparation Method thereof and Use thereof | Jan 28, 23 | Apr 10, 25 | Not available |
| 2025/0092,089 | METHODS FOR PURIFYING TARGET BIOLOGICS | Sep 19, 24 | Mar 20, 25 | Not available |
| 2025/0084,138 | POLYPEPTIDE HAVING EFFECT OF INHIBITING PROLIFERATION OF LEUKEMIA CELLS | Mar 07, 19 | Mar 13, 25 | Not available |
| 2025/0066,832 | CELL CULTURE METHODS | Nov 15, 24 | Feb 27, 25 | Not available |
| 2025/0066,415 | SYSTEMS FOR EXTRACTING PROTEINS FROM A BLOOD-BASED MATERIAL | Nov 12, 24 | Feb 27, 25 | Not available |
| 2025/0051,824 | CELL CULTURE METHODS | Aug 23, 24 | Feb 13, 25 | Not available |
| 2025/0034,231 | ANTI-VEGF PROTEIN COMPOSITIONS AND METHODS FOR PRODUCING THE SAME | Oct 16, 24 | Jan 30, 25 | Not available |
| 2025/0034,204 | METHODS OF PURIFYING POLYPEPTIDES | Oct 16, 24 | Jan 30, 25 | Genentech, Inc. |
| 2025/0019,394 | METHOD FOR PRODUCING ACTIVE PHARMACEUTICAL INGREDIENT OF BIOPHARMACEUTICAL, SYSTEM FOR PRODUCING ACTIVE PHARMACEUTICAL INGREDIENT OF BIOPHARMACEUTICAL, AND ACTIVE PHARMACEUTICAL INGREDIENT OF BIOPHARMACEUTICAL | Sep 27, 24 | Jan 16, 25 | Not available |
| 2025/0011,395 | PROCESS OF PURIFICATION OF PROTEIN | Sep 23, 24 | Jan 09, 25 | Not available |
| 2024/0417,442 | AFLIBERCEPT ATTRIBUTES AND METHODS OF CHARACTERIZING AND MODIFYING THEREOF | Aug 09, 24 | Dec 19, 24 | Not available |
| 2024/0417,427 | Integrated Continuous Manufacturing of Therapeutic Protein Drug Substances | Aug 27, 24 | Dec 19, 24 | Genzyme Corporation |
| 2024/0409,524 | COMPOUND HAVING PHOTOCLEAVABLE MOIETY, CONJUGATE, AND SCREENING METHOD USING SAME | Sep 29, 22 | Dec 12, 24 | Not available |
| 2024/0383,945 | PURIFICATION METHOD OF ANTIBODY COMPOSITION | May 06, 22 | Nov 21, 24 | CHIOME BIOSCIENCE INC. |
| 2024/0384,221 | Compositions and Methods For Semi-Automated Protein Production | May 08, 24 | Nov 21, 24 | Not available |
| 2024/0376,146 | PURIFICATION OF ANTIBODIES BY MIXED MODE CHROMATOGRAPHY | Sep 29, 23 | Nov 14, 24 | Hoffmann-La Roche, Inc. |
| 2024/0350,944 | SEPARATING AND QUANTIFYING UNBOUND TARGET ANALYTES FROM BIOLOGICAL SAMPLES | Apr 29, 24 | Oct 24, 24 | ARUP Laboratories, Inc. |
| 2024/0352,063 | End-to-End Continuous Purification System | Jan 17, 24 | Oct 24, 24 | PAK Biosolutions Inc. |
| 2024/0345,048 | SYSTEMS AND METHODS FOR FAILURE MODE DETECTION IN PROCESS CHROMATOGRAPHY | May 24, 24 | Oct 17, 24 | Not available |